Olympus introduces VISERA ELITE III surgical imaging platform in United States

USA—Olympus Corporation has introduced its VISERA ELITE III surgical imaging platform to the United States market, bringing enhanced visualization capabilities to operating rooms nationwide.

The platform aims to improve surgical precision, streamline workflows, and offer adaptability across multiple medical specialties.

This launch represents the third major product to emerge from SONY Olympus Medical, a collaborative partnership that began in 2013.

The alliance continues to push boundaries in medical imaging technology through combined expertise and innovation.

Comprehensive imaging features in one system

The VISERA ELITE III platform integrates several cutting-edge technologies into a single, software-driven system.

Continuous auto focus (CAF) ensures sharp, clear images throughout procedures, while true 4K and 3D imaging capabilities provide surgeons with exceptional detail and depth perception.

The system incorporates yellow enhancement (YE) and narrow band imaging (NBI) technology, which help clinicians identify critical anatomical structures more effectively.

Additionally, the platform supports both Endoeye rigid and flexible videoscopes, accommodating different surgical approaches and preferences.

Fluorescence-guided surgery features include IR/ICG imaging with full 4K white light and high contrast magenta mode.

These tools enable surgeons to assess tissue perfusion and visualize structures that might otherwise remain hidden during conventional imaging.

Wide-ranging specialty applications

The platform serves multiple surgical disciplines, including arthroscopy, bariatric surgery, general surgery, gynecology, hepatopancreatobiliary transplant procedures, thoracic surgery, and urology.

Olympus designed the system to support minimally invasive techniques across these varied fields while maintaining compatibility with previous generation videoendoscopes.

Clinical advantages extend beyond superior imaging quality.

Surgeons using the 3D horizon lock feature report reduced suturing time compared to traditional 2D imaging.

The platform’s perfusion assessment capabilities through IR/ICG imaging allow real-time evaluation of blood flow to tissues, providing valuable information during critical surgical moments.

Strategic design for modern operating rooms

The compact platform accommodates Olympus’ complete scope portfolio while offering integrated IT tools for video streaming and workflow automation.

 Darryl Rock, vice president and surgical solutions regional business lead at Olympus Americas, describes VISERA ELITE III as more than hardware—it functions as a strategic enabler for contemporary operating rooms.

The system serves as a cornerstone of Olympus’ SEE. TREAT. CONNECT. ecosystem.

Its software-based architecture allows healthcare facilities to scale capabilities while managing capital investment effectively. Hospitals can selectively activate advanced features such as 3D and infrared imaging based on specific departmental needs and budgets.

Safety considerations and future investment

Olympus emphasizes that while the device excels at treatment, video observation, and laparoscopic diagnosis, TYPE BF endoscopes connected to this platform must not contact the heart directly due to potential cardiac complications.

In December 2025, Olympus committed USD150 million to a new venture capital fund targeting promising medical technology startups in the gastrointestinal, respiratory, and urology sectors.